Share Price and Basic Stock Data
Last Updated: June 27, 2025, 8:00 pm
PEG Ratio | 3.54 |
---|
Competitors of Hindustan Zinc Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Hindustan Zinc Ltd | 1,90,668 Cr. | 451 | 717/378 | 18.4 | 31.4 | 6.43 % | 60.8 % | 72.5 % | 2.00 |
Industry Average | 190,668.00 Cr | 451.00 | 18.40 | 31.40 | 6.43% | 60.80% | 72.50% | 2.00 |
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 8,797 | 9,387 | 8,336 | 7,866 | 8,509 | 7,282 | 6,792 | 7,310 | 7,550 | 8,130 | 8,242 | 8,556 | 9,041 |
Expenses | 3,834 | 4,249 | 3,928 | 4,159 | 4,250 | 3,934 | 3,653 | 3,790 | 3,896 | 4,179 | 4,138 | 4,098 | 4,258 |
Operating Profit | 4,963 | 5,138 | 4,408 | 3,707 | 4,259 | 3,348 | 3,139 | 3,520 | 3,654 | 3,951 | 4,104 | 4,458 | 4,783 |
OPM % | 56% | 55% | 53% | 47% | 50% | 46% | 46% | 48% | 48% | 49% | 50% | 52% | 53% |
Other Income | 277 | 310 | 367 | 349 | 356 | 287 | 231 | 305 | 280 | 277 | 185 | 221 | 230 |
Interest | 66 | 44 | 51 | 62 | 176 | 218 | 232 | 243 | 262 | 256 | 319 | 285 | 251 |
Depreciation | 816 | 731 | 798 | 807 | 928 | 801 | 825 | 904 | 936 | 843 | 875 | 903 | 1,013 |
Profit before tax | 4,358 | 4,673 | 3,926 | 3,187 | 3,511 | 2,616 | 2,313 | 2,678 | 2,736 | 3,129 | 3,095 | 3,491 | 3,749 |
Tax % | 33% | 34% | 32% | 32% | 26% | 25% | 25% | 24% | 25% | 25% | 26% | 24% | 21% |
Net Profit | 2,929 | 3,093 | 2,681 | 2,157 | 2,589 | 1,970 | 1,737 | 2,038 | 2,042 | 2,358 | 2,298 | 2,647 | 2,976 |
EPS in Rs | 6.93 | 7.32 | 6.35 | 5.10 | 6.13 | 4.66 | 4.11 | 4.82 | 4.83 | 5.58 | 5.44 | 6.26 | 7.04 |
Last Updated: May 31, 2025, 8:59 am
Below is a detailed analysis of the quarterly data for Hindustan Zinc Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 9,041.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,556.00 Cr. (Dec 2024) to 9,041.00 Cr., marking an increase of 485.00 Cr..
- For Expenses, as of Mar 2025, the value is 4,258.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,098.00 Cr. (Dec 2024) to 4,258.00 Cr., marking an increase of 160.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 4,783.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,458.00 Cr. (Dec 2024) to 4,783.00 Cr., marking an increase of 325.00 Cr..
- For OPM %, as of Mar 2025, the value is 53.00%. The value appears strong and on an upward trend. It has increased from 52.00% (Dec 2024) to 53.00%, marking an increase of 1.00%.
- For Other Income, as of Mar 2025, the value is 230.00 Cr.. The value appears strong and on an upward trend. It has increased from 221.00 Cr. (Dec 2024) to 230.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Mar 2025, the value is 251.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 285.00 Cr. (Dec 2024) to 251.00 Cr., marking a decrease of 34.00 Cr..
- For Depreciation, as of Mar 2025, the value is 1,013.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 903.00 Cr. (Dec 2024) to 1,013.00 Cr., marking an increase of 110.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 3,749.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,491.00 Cr. (Dec 2024) to 3,749.00 Cr., marking an increase of 258.00 Cr..
- For Tax %, as of Mar 2025, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Dec 2024) to 21.00%, marking a decrease of 3.00%.
- For Net Profit, as of Mar 2025, the value is 2,976.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,647.00 Cr. (Dec 2024) to 2,976.00 Cr., marking an increase of 329.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 7.04. The value appears strong and on an upward trend. It has increased from 6.26 (Dec 2024) to 7.04, marking an increase of 0.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 6:27 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 13,636 | 14,788 | 14,181 | 17,273 | 22,082 | 21,118 | 18,561 | 22,629 | 29,440 | 34,098 | 28,934 | 33,969 |
Expenses | 6,717 | 7,338 | 7,923 | 7,534 | 9,812 | 10,448 | 9,691 | 10,957 | 13,214 | 16,577 | 15,253 | 16,673 |
Operating Profit | 6,919 | 7,450 | 6,258 | 9,739 | 12,270 | 10,670 | 8,870 | 11,672 | 16,226 | 17,521 | 13,681 | 17,296 |
OPM % | 51% | 50% | 44% | 56% | 56% | 51% | 48% | 52% | 55% | 51% | 47% | 51% |
Other Income | 1,881 | 2,788 | 3,127 | 2,474 | 1,956 | 1,782 | 1,911 | 1,819 | 1,082 | 1,373 | 1,083 | 913 |
Interest | 45 | 24 | 17 | 202 | 246 | 113 | 112 | 386 | 290 | 333 | 955 | 1,111 |
Depreciation | 785 | 644 | 745 | 1,811 | 1,483 | 1,883 | 2,279 | 2,531 | 2,917 | 3,264 | 3,466 | 3,634 |
Profit before tax | 7,970 | 9,570 | 8,623 | 10,200 | 12,497 | 10,456 | 8,390 | 10,574 | 14,101 | 15,297 | 10,343 | 13,464 |
Tax % | 13% | 15% | 5% | 18% | 26% | 24% | 19% | 25% | 32% | 31% | 25% | 24% |
Net Profit | 6,905 | 8,178 | 8,175 | 8,316 | 9,276 | 7,956 | 6,805 | 7,980 | 9,630 | 10,520 | 7,787 | 10,279 |
EPS in Rs | 16.34 | 19.35 | 19.35 | 19.68 | 21.95 | 18.83 | 16.11 | 18.89 | 22.79 | 24.90 | 18.43 | 24.33 |
Dividend Payout % | 21% | 23% | 144% | 149% | 36% | 106% | 102% | 113% | 79% | 303% | 71% | 119% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 18.44% | -0.04% | 1.72% | 11.54% | -14.23% | -14.47% | 17.27% | 20.68% | 9.24% | -25.98% | 32.00% |
Change in YoY Net Profit Growth (%) | 0.00% | -18.47% | 1.76% | 9.82% | -25.77% | -0.24% | 31.73% | 3.41% | -11.43% | -35.22% | 57.98% |
Hindustan Zinc Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 13% |
3 Years: | 5% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 9% |
3 Years: | 3% |
TTM: | 33% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 18% |
3 Years: | 22% |
1 Year: | -33% |
Return on Equity | |
---|---|
10 Years: | 28% |
5 Years: | 38% |
3 Years: | 55% |
Last Year: | 73% |
Last Updated: Unknown
Balance Sheet
Last Updated: May 13, 2025, 3:24 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 |
Reserves | 36,573 | 42,508 | 36,540 | 29,960 | 35,087 | 32,760 | 39,465 | 31,468 | 33,437 | 12,097 | 14,388 | 12,445 |
Borrowings | 0 | 0 | 0 | 7,908 | 0 | 2,538 | 611 | 7,201 | 2,844 | 11,881 | 8,722 | 10,964 |
Other Liabilities | 4,259 | 5,639 | 15,810 | 13,082 | 7,000 | 6,315 | 6,054 | 6,213 | 7,545 | 10,631 | 9,949 | 10,164 |
Total Liabilities | 41,677 | 48,992 | 53,195 | 51,795 | 42,932 | 42,458 | 46,975 | 45,727 | 44,671 | 35,454 | 33,904 | 34,418 |
Fixed Assets | 9,147 | 9,446 | 10,385 | 9,993 | 11,302 | 14,778 | 16,469 | 16,808 | 17,396 | 17,620 | 18,055 | 18,488 |
CWIP | 1,541 | 2,005 | 2,428 | 3,071 | 3,220 | 2,254 | 2,489 | 1,922 | 2,075 | 2,107 | 1,529 | 2,552 |
Investments | 22,506 | 27,254 | 35,221 | 23,783 | 20,222 | 19,488 | 20,329 | 12,957 | 15,052 | 10,107 | 10,452 | 9,971 |
Other Assets | 8,482 | 10,288 | 5,161 | 14,948 | 8,188 | 5,938 | 7,688 | 14,040 | 10,148 | 5,620 | 3,868 | 3,407 |
Total Assets | 41,677 | 48,992 | 53,195 | 51,795 | 42,932 | 42,458 | 46,975 | 45,727 | 44,671 | 35,454 | 33,904 | 34,418 |
Below is a detailed analysis of the balance sheet data for Hindustan Zinc Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 845.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 845.00 Cr..
- For Reserves, as of Mar 2025, the value is 12,445.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,388.00 Cr. (Mar 2024) to 12,445.00 Cr., marking a decrease of 1,943.00 Cr..
- For Borrowings, as of Mar 2025, the value is 10,964.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 8,722.00 Cr. (Mar 2024) to 10,964.00 Cr., marking an increase of 2,242.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 10,164.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,949.00 Cr. (Mar 2024) to 10,164.00 Cr., marking an increase of 215.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 34,418.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 33,904.00 Cr. (Mar 2024) to 34,418.00 Cr., marking an increase of 514.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 18,488.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,055.00 Cr. (Mar 2024) to 18,488.00 Cr., marking an increase of 433.00 Cr..
- For CWIP, as of Mar 2025, the value is 2,552.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,529.00 Cr. (Mar 2024) to 2,552.00 Cr., marking an increase of 1,023.00 Cr..
- For Investments, as of Mar 2025, the value is 9,971.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,452.00 Cr. (Mar 2024) to 9,971.00 Cr., marking a decrease of 481.00 Cr..
- For Other Assets, as of Mar 2025, the value is 3,407.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,868.00 Cr. (Mar 2024) to 3,407.00 Cr., marking a decrease of 461.00 Cr..
- For Total Assets, as of Mar 2025, the value is 34,418.00 Cr.. The value appears strong and on an upward trend. It has increased from 33,904.00 Cr. (Mar 2024) to 34,418.00 Cr., marking an increase of 514.00 Cr..
Notably, the Reserves (12,445.00 Cr.) exceed the Borrowings (10,964.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 6.00 | 7.00 | 6.00 | 2.00 | 12.00 | 8.00 | -603.00 | 4.00 | 14.00 | 6.00 | 5.00 | 7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12 | 11 | 16 | 3 | 3 | 3 | 3 | 7 | 7 | 9 | 4 | 2 |
Inventory Days | 620 | |||||||||||
Days Payable | 225 | |||||||||||
Cash Conversion Cycle | 407 | 11 | 16 | 3 | 3 | 3 | 3 | 7 | 7 | 9 | 4 | 2 |
Working Capital Days | 11 | -1 | -14 | -347 | -208 | -67 | -54 | -44 | -56 | -27 | -37 | -49 |
ROCE % | 23% | 20% | 25% | 20% | 26% | 33% | 28% | 22% | 26% | 37% | 50% | 46% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
DSP Natural Resources and New Energy Fund | 548,291 | 2.08 | 27.46 | 548,291 | 2025-04-22 17:25:32 | 0% |
ICICI Prudential Manufacturing Fund | 206,555 | 0.15 | 10.34 | 206,555 | 2025-04-22 17:25:32 | 0% |
Motilal Oswal Nifty Midcap 150 Index Fund | 139,111 | 0.37 | 6.97 | 139,111 | 2025-04-22 17:25:32 | 0% |
ICICI Prudential MidCap Fund | 128,384 | 0.1 | 6.43 | 128,384 | 2025-04-22 17:25:32 | 0% |
Nippon India ETF Nifty Midcap 150 | 127,015 | 0.37 | 6.36 | 127,015 | 2025-04-22 17:25:32 | 0% |
Nippon India Nifty Midcap 150 Index Fund | 118,283 | 0.37 | 5.92 | 118,283 | 2025-04-22 17:25:32 | 0% |
Motilal Oswal Nifty 500 Index Fund | 26,579 | 0.07 | 1.33 | 26,579 | 2025-04-22 17:25:32 | 0% |
Aditya Birla Sun Life Nifty Midcap 150 Index Fund | 20,390 | 0.37 | 1.02 | 20,390 | 2025-04-22 17:25:32 | 0% |
Motilal Oswal BSE Quality Index Fund | 9,023 | 1.48 | 0.45 | 9,023 | 2025-04-22 17:25:32 | 0% |
Motilal Oswal BSE Quality ETF | 5,687 | 1.5 | 0.28 | 5,687 | 2025-04-22 17:25:32 | 0% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
Diluted EPS (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
Cash EPS (Rs.) | 26.57 | 32.60 | 29.69 | 24.88 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 35.96 | 30.61 | 81.14 | 76.48 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 35.96 | 30.61 | 81.14 | 76.48 |
Revenue From Operations / Share (Rs.) | 68.48 | 80.71 | 69.68 | 53.56 |
PBDIT / Share (Rs.) | 34.86 | 44.70 | 41.28 | 31.93 |
PBIT / Share (Rs.) | 26.66 | 36.97 | 34.38 | 25.94 |
PBT / Share (Rs.) | 24.40 | 36.18 | 33.37 | 25.03 |
Net Profit / Share (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
NP After MI And SOA / Share (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
PBDIT Margin (%) | 50.91 | 55.38 | 59.24 | 59.61 |
PBIT Margin (%) | 38.92 | 45.81 | 49.33 | 48.43 |
PBT Margin (%) | 35.62 | 44.83 | 47.89 | 46.72 |
Net Profit Margin (%) | 26.81 | 30.82 | 32.70 | 35.26 |
NP After MI And SOA Margin (%) | 26.81 | 30.82 | 32.70 | 35.26 |
Return on Networth / Equity (%) | 51.06 | 81.27 | 28.08 | 24.69 |
Return on Capital Employeed (%) | 48.85 | 86.71 | 37.65 | 28.95 |
Return On Assets (%) | 22.89 | 29.63 | 21.55 | 17.45 |
Long Term Debt / Equity (X) | 0.27 | 0.11 | 0.06 | 0.13 |
Total Debt / Equity (X) | 0.55 | 0.91 | 0.08 | 0.22 |
Asset Turnover Ratio (%) | 0.83 | 0.85 | 0.00 | 0.00 |
Current Ratio (X) | 1.16 | 0.84 | 3.94 | 3.12 |
Quick Ratio (X) | 0.98 | 0.74 | 3.61 | 2.94 |
Dividend Payout Ratio (NP) (%) | 70.79 | 303.50 | 78.99 | 0.00 |
Dividend Payout Ratio (CP) (%) | 48.92 | 231.58 | 60.62 | 0.00 |
Earning Retention Ratio (%) | 29.21 | -203.50 | 21.01 | 0.00 |
Cash Earning Retention Ratio (%) | 51.08 | -131.58 | 39.38 | 0.00 |
Interest Coverage Ratio (X) | 15.42 | 56.71 | 60.14 | 34.95 |
Interest Coverage Ratio (Post Tax) (X) | 9.12 | 32.56 | 34.67 | 21.67 |
Enterprise Value (Cr.) | 131756.63 | 134390.50 | 127908.25 | 113083.00 |
EV / Net Operating Revenue (X) | 4.55 | 3.94 | 4.34 | 5.00 |
EV / EBITDA (X) | 8.94 | 7.12 | 7.33 | 8.38 |
MarketCap / Net Operating Revenue (X) | 4.27 | 3.64 | 4.44 | 5.09 |
Retention Ratios (%) | 29.20 | -203.50 | 21.00 | 0.00 |
Price / BV (X) | 8.13 | 9.59 | 3.82 | 3.57 |
Price / Net Operating Revenue (X) | 4.27 | 3.64 | 4.44 | 5.09 |
EarningsYield | 0.06 | 0.08 | 0.07 | 0.06 |
After reviewing the key financial ratios for Hindustan Zinc Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For Diluted EPS (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For Cash EPS (Rs.), as of Mar 24, the value is 26.57. This value is within the healthy range. It has decreased from 32.60 (Mar 23) to 26.57, marking a decrease of 6.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 35.96. It has increased from 30.61 (Mar 23) to 35.96, marking an increase of 5.35.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 35.96. It has increased from 30.61 (Mar 23) to 35.96, marking an increase of 5.35.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 68.48. It has decreased from 80.71 (Mar 23) to 68.48, marking a decrease of 12.23.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 34.86. This value is within the healthy range. It has decreased from 44.70 (Mar 23) to 34.86, marking a decrease of 9.84.
- For PBIT / Share (Rs.), as of Mar 24, the value is 26.66. This value is within the healthy range. It has decreased from 36.97 (Mar 23) to 26.66, marking a decrease of 10.31.
- For PBT / Share (Rs.), as of Mar 24, the value is 24.40. This value is within the healthy range. It has decreased from 36.18 (Mar 23) to 24.40, marking a decrease of 11.78.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For PBDIT Margin (%), as of Mar 24, the value is 50.91. This value is within the healthy range. It has decreased from 55.38 (Mar 23) to 50.91, marking a decrease of 4.47.
- For PBIT Margin (%), as of Mar 24, the value is 38.92. This value exceeds the healthy maximum of 20. It has decreased from 45.81 (Mar 23) to 38.92, marking a decrease of 6.89.
- For PBT Margin (%), as of Mar 24, the value is 35.62. This value is within the healthy range. It has decreased from 44.83 (Mar 23) to 35.62, marking a decrease of 9.21.
- For Net Profit Margin (%), as of Mar 24, the value is 26.81. This value exceeds the healthy maximum of 10. It has decreased from 30.82 (Mar 23) to 26.81, marking a decrease of 4.01.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 26.81. This value exceeds the healthy maximum of 20. It has decreased from 30.82 (Mar 23) to 26.81, marking a decrease of 4.01.
- For Return on Networth / Equity (%), as of Mar 24, the value is 51.06. This value is within the healthy range. It has decreased from 81.27 (Mar 23) to 51.06, marking a decrease of 30.21.
- For Return on Capital Employeed (%), as of Mar 24, the value is 48.85. This value is within the healthy range. It has decreased from 86.71 (Mar 23) to 48.85, marking a decrease of 37.86.
- For Return On Assets (%), as of Mar 24, the value is 22.89. This value is within the healthy range. It has decreased from 29.63 (Mar 23) to 22.89, marking a decrease of 6.74.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.27. This value is within the healthy range. It has increased from 0.11 (Mar 23) to 0.27, marking an increase of 0.16.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.55. This value is within the healthy range. It has decreased from 0.91 (Mar 23) to 0.55, marking a decrease of 0.36.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has decreased from 0.85 (Mar 23) to 0.83, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 1.5. It has increased from 0.84 (Mar 23) to 1.16, marking an increase of 0.32.
- For Quick Ratio (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 23) to 0.98, marking an increase of 0.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 70.79. This value exceeds the healthy maximum of 50. It has decreased from 303.50 (Mar 23) to 70.79, marking a decrease of 232.71.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 48.92. This value is within the healthy range. It has decreased from 231.58 (Mar 23) to 48.92, marking a decrease of 182.66.
- For Earning Retention Ratio (%), as of Mar 24, the value is 29.21. This value is below the healthy minimum of 40. It has increased from -203.50 (Mar 23) to 29.21, marking an increase of 232.71.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 51.08. This value is within the healthy range. It has increased from -131.58 (Mar 23) to 51.08, marking an increase of 182.66.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 15.42. This value is within the healthy range. It has decreased from 56.71 (Mar 23) to 15.42, marking a decrease of 41.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.12. This value is within the healthy range. It has decreased from 32.56 (Mar 23) to 9.12, marking a decrease of 23.44.
- For Enterprise Value (Cr.), as of Mar 24, the value is 131,756.63. It has decreased from 134,390.50 (Mar 23) to 131,756.63, marking a decrease of 2,633.87.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.55. This value exceeds the healthy maximum of 3. It has increased from 3.94 (Mar 23) to 4.55, marking an increase of 0.61.
- For EV / EBITDA (X), as of Mar 24, the value is 8.94. This value is within the healthy range. It has increased from 7.12 (Mar 23) to 8.94, marking an increase of 1.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.27. This value exceeds the healthy maximum of 3. It has increased from 3.64 (Mar 23) to 4.27, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 24, the value is 29.20. This value is below the healthy minimum of 30. It has increased from -203.50 (Mar 23) to 29.20, marking an increase of 232.70.
- For Price / BV (X), as of Mar 24, the value is 8.13. This value exceeds the healthy maximum of 3. It has decreased from 9.59 (Mar 23) to 8.13, marking a decrease of 1.46.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.27. This value exceeds the healthy maximum of 3. It has increased from 3.64 (Mar 23) to 4.27, marking an increase of 0.63.
- For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to 0.06, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Zinc Ltd:
- Net Profit Margin: 26.81%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 48.85% (Industry Average ROCE: 60.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 51.06% (Industry Average ROE: 72.5%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.12
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.4 (Industry average Stock P/E: 18.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.55
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 26.81%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Metals - Non Ferrous - Zinc/Zinc Alloys - Products | Yashad Bhawan, Yashadgarh, Udaipur Rajasthan 313004 | Hzl.ir@vedanta.co.in http://www.hzlindia.com |
Management | |
---|---|
Name | Position Held |
Ms. Priya Agarwal Hebbar | Non Exe. Non Ind Chairperson |
Mr. Arun Misra | WholeTime Director & CEO |
Mr. Navin Agarwal | Non Executive Director |
Mr. Akhilesh Joshi | Ind. Non-Executive Director |
Mr. Kannan Ramamirtham | Ind. Non-Executive Director |
Ms. Pallavi Joshi Bakhru | Ind. Non-Executive Director |
Dr. Veena Kumari Dermal | Non Exe. & Nominee Director |
Mrs. Nirupama Kotru | Non Exe. & Nominee Director |
Ms. Farida M Naik | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Hindustan Zinc Ltd?
Hindustan Zinc Ltd's intrinsic value (as of 29 June 2025) is 356.65 — 20.92% lower the current market price of 451.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,90,668 Cr. market cap, FY2025-2026 high/low of 717/378, reserves of 12,445 Cr, and liabilities of 34,418 Cr.
What is the Market Cap of Hindustan Zinc Ltd?
The Market Cap of Hindustan Zinc Ltd is 1,90,668 Cr..
What is the current Stock Price of Hindustan Zinc Ltd as on 29 June 2025?
The current stock price of Hindustan Zinc Ltd as on 29 June 2025 is 451.
What is the High / Low of Hindustan Zinc Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Zinc Ltd stocks is ₹717/378.
What is the Stock P/E of Hindustan Zinc Ltd?
The Stock P/E of Hindustan Zinc Ltd is 18.4.
What is the Book Value of Hindustan Zinc Ltd?
The Book Value of Hindustan Zinc Ltd is 31.4.
What is the Dividend Yield of Hindustan Zinc Ltd?
The Dividend Yield of Hindustan Zinc Ltd is 6.43 %.
What is the ROCE of Hindustan Zinc Ltd?
The ROCE of Hindustan Zinc Ltd is 60.8 %.
What is the ROE of Hindustan Zinc Ltd?
The ROE of Hindustan Zinc Ltd is 72.5 %.
What is the Face Value of Hindustan Zinc Ltd?
The Face Value of Hindustan Zinc Ltd is 2.00.